Quarterly report · Q1
2784.TEDINET S100RN02
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥709.1bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥2.70T | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥657.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥5.8bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥3.1bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥6.4bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥32.8bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.7bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥6.4bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.0bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥25.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.1bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.1bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥2.2bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥1.39T | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥1.34T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.33T | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥909.2bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥851.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥479.9bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥488.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥475.5bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥169.4bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥160.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥20.15 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥127.42 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.5 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.8% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥8.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥8.4bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥129m |
| jpcrp040300-q1r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥631.6bn |
| jpcrp040300-q1r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥626.8bn |
| jpcrp040300-q1r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥4.8bn |
| jpcrp040300-q1r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥5.3bn |
| jpcrp040300-q1r_E02962-000Manufacturing Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥12.3bn |
| jpcrp040300-q1r_E02962-000Manufacturing Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥8.8bn |
| jpcrp040300-q1r_E02962-000Manufacturing Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥3.5bn |
| jpcrp040300-q1r_E02962-000Manufacturing Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥442m |
| jpcrp040300-q1r_E02962-000Medical Related Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥8.9bn |
| jpcrp040300-q1r_E02962-000Medical Related Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥8.9bn |
| jpcrp040300-q1r_E02962-000Medical Related Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥82m |
| jpcrp040300-q1r_E02962-000Self Medication Products Wholesaling Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥64.6bn |
| jpcrp040300-q1r_E02962-000Self Medication Products Wholesaling Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥64.5bn |
| jpcrp040300-q1r_E02962-000Self Medication Products Wholesaling Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥153m |
| jpcrp040300-q1r_E02962-000Self Medication Products Wholesaling Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥770m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥717.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥709.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥5.7bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥7.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥7.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | ¥82m |
| jpcrp040300-q1r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥585.4bn |
| jpcrp040300-q1r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥580.9bn |
| jpcrp040300-q1r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥4.5bn |
| jpcrp040300-q1r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.4bn |
| jpcrp040300-q1r_E02962-000Manufacturing Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥11.0bn |
| jpcrp040300-q1r_E02962-000Manufacturing Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥7.9bn |
| jpcrp040300-q1r_E02962-000Manufacturing Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥3.1bn |
| jpcrp040300-q1r_E02962-000Manufacturing Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥207m |
| jpcrp040300-q1r_E02962-000Medical Related Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥8.8bn |
| jpcrp040300-q1r_E02962-000Medical Related Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥8.8bn |
| jpcrp040300-q1r_E02962-000Medical Related Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥92m |
| jpcrp040300-q1r_E02962-000Self Medication Products Wholesaling Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥59.6bn |
| jpcrp040300-q1r_E02962-000Self Medication Products Wholesaling Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥59.5bn |
| jpcrp040300-q1r_E02962-000Self Medication Products Wholesaling Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥142m |
| jpcrp040300-q1r_E02962-000Self Medication Products Wholesaling Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥448m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥664.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥657.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥3.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 371
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0016 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 317900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 317900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0016 | |
| Cash and deposits | Prior1YearInstant | 160122000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 169387000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 623654000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 657398000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 145349000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 141464000000 | JPY |
| Work in process | Prior1YearInstant | 1469000000 | JPY |
| Work in process | CurrentQuarterInstant | 1822000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 5972000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 6359000000 | JPY |
| Other ca | Prior1YearInstant | 98379000000 | JPY |
| Other ca | CurrentQuarterInstant | 93826000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -419000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -439000000 | JPY |
| Current assets | Prior1YearInstant | 1034527000000 | JPY |
| Current assets | CurrentQuarterInstant | 1069819000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 63702000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 62762000000 | JPY |
| Land | Prior1YearInstant | 72127000000 | JPY |
| Land | CurrentQuarterInstant | 72083000000 | JPY |
| Other net ppe | Prior1YearInstant | 40992000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 44701000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 176821000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 179547000000 | JPY |
| Goodwill | Prior1YearInstant | 2545000000 | JPY |
| Goodwill | CurrentQuarterInstant | 2440000000 | JPY |
| Other ia | Prior1YearInstant | 15314000000 | JPY |
| Other ia | CurrentQuarterInstant | 14821000000 | JPY |
| Intangible assets | Prior1YearInstant | 17860000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 17261000000 | JPY |
| Investment securities | Prior1YearInstant | 91555000000 | JPY |
| Investment securities | CurrentQuarterInstant | 100373000000 | JPY |
| Other ioa | Prior1YearInstant | 24120000000 | JPY |
| Other ioa | CurrentQuarterInstant | 27184000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -5033000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -5045000000 | JPY |
| Investments and other assets | Prior1YearInstant | 110643000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 122511000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 305325000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 319321000000 | JPY |
| Assets | Prior1YearInstant | 1339852000000 | JPY |
| Assets | CurrentQuarterInstant | 1389140000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 780343000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 829054000000 | JPY |
| Short term loans payable | Prior1YearInstant | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |